Volume : 13, Issue : 10, October – 2026
Title:
DESIGN AND IN-VITRO ASSESSMENT OF CISPLATIN-LOADED SOLID LIPID NANO PARTICLES
Authors :
Mrs. P. Sudharani, Bharath Chikkudu, Bhavani Thandu,Bitla Kavya, Deepthi Budige,Hari Priya Kondaj
Abstract :
The present study was aimed at the formulation and evaluation of Cisplatin-loaded Solid Lipid Nanoparticles (SLNs) to improve drug encapsulation efficiency, provide sustained drug release, and enhance formulation stability. Four formulations (F1–F4) were prepared using varying concentrations of lipids and evaluated for their physicochemical properties, drug-excipient compatibility, particle size, zeta potential, entrapment efficiency, in vitro drug release, and stability.The particle size of the developed SLNs ranged from 116 to 151 nm, with formulation F4 exhibiting the smallest particle size (116 nm). Zeta potential values ranged from −23 mV to −27 mV, indicating acceptable physical stability of the formulations. Entrapment efficiency increased with increasing lipid concentration, and formulation F4 showed the highest entrapment efficiency of 83.50%.In vitro drug release studies demonstrated a sustained release profile over an 8-hour period, with the optimized formulation F4 exhibiting the highest cumulative drug release of 95.98%. Stability studies performed under different storage conditions (25°C/60% RH, 30°C/75% RH, and 40°C/75% RH) for three months indicated no significant changes in the physicochemical properties or drug release characteristics of the optimized formulation, confirming its stability.The findings of the present investigation suggest that Cisplatin-loaded Solid Lipid Nanoparticles represent a promising drug delivery system with improved encapsulation efficiency, sustained drug release, and enhanced stability. Among the formulations developed, F4 was identified as the optimized formulation based on its superior performance. Further in vivo studies are recommended to establish the therapeutic potential and clinical applicability of the developed SLN formulation.
Keywords: Cisplatin, Solid Lipid Nanoparticles, SLNs, Entrapment Efficiency, Sustained Drug Release, Zeta Potential, Stability Studies.
Cite This Article:
Please cite this article in press P Sudharani et al., Design And In-Vitro Assessment Of Cisplatin-Loaded Solid Lipid Nano Particles.,. Indo Am. J. P. Sci, 2026; 13(10).
REFERENCES:
1. Müller RH, MaÈder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. European journal of pharmaceutics and biopharmaceutics. 2000 Jul 3;50(1):161-77.
2. García-Pinel B, Porras-Alcalá C, Ortega-Rodríguez A, Sarabia F, Prados J, Melguizo C, López-Romero JM. Lipid-based nanoparticles: Application and recent advances in cancer treatment. Nanomaterials. 2019 Apr;9(4):638.
3. Lin CH, Chen CH, Lin ZC, Fang JY. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. Journal of food and drug analysis. 2017 Apr 1;25(2):219-34.
4. Montenegro L, Lai F, Offerta A, Sarpietro MG, Micicche L, Maccioni AM, Valenti D, Fadda AM. From nanoemulsions to nanostructured lipid carriers: A relevant development in dermal delivery of drugs and cosmetics. Journal of Drug Delivery Science and Technology. 2016 Apr 1;32:100-12.
5. Dudhipala N, Veerabrahma K. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug delivery. 2016 Feb 12;23(2):395-404.
6. Sarathchandiran I. A review on nanotechnology in solid lipid nanoparticles. IJPDT. 2012;2(1):45-61.
7. Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for peptide and protein delivery-liposomes versus lipid nanoprticles. International journal of nanomedicine. 2007 Dec;2(4):595.
8. Zhang XG, Teng DY, Wu ZM, Wang X, Wang Z, Yu DM, Li CX. PEG- grafted citosan nanoparticles as an injectable carrier for sustained protein release. Journal of materials Science: materials inMedicine. 2008 Dec 1:19(12):3525-33.
9. Fahr A, Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert opinion on drug delivery. 2007 Jul 1;4(4):403-16.
10. Rupenagunta A, Somasundaram I, Ravichandiram V, Kausalya J, Senthilnathan B. Solid lipid nanoparticles-A versatile carrier system. J Pharm Res. 2011 Jul;4(7):2069-75.
11. Garud A, Singh D, Garud N. Solid lipid nanoparticles (SLN): method, characterization and applications. International current pharmaceutical journal. 2012 Oct 3;1(11):384-93.
12. Munireddy M, Thakur RS, Patel R, Mamatha MC. Solid lipid nanoparticles: An effective drug system-A Review. Am. J. PharmTech Res. 2012;2(3):2249-3387.
13. Mahajan PS, Mahajan KB, Darekar AB. A review on solid lipid nanoparticle (SLN): an advanced treatment modality. Int. J. Pharmaceut. Sci. Res. 2015 Sep 1;6(9).
14. Schwarz C, Mehnert W, Lucks JS, Müller RH. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. Journal of Controlled Release. 1994 Apr 1;30(1):83-96.
15. Speiser P. Lipidnanopellets als Trägersystem für Arzneimittel zur peroralen Anwendung. European Patent EP. 1990;167825:0167825.
16. Domb AJ, inventor; Nova Pharmaceutical Corp, assignee. Lipsopheres for controlled delivery of substances. United States patent US 5,188,837. 1993 Feb 23.